chr16-67930572-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001907.3(CTRL):c.335G>A(p.Ser112Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000917 in 1,613,970 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001907.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CTRL | NM_001907.3 | c.335G>A | p.Ser112Asn | missense_variant | 5/7 | ENST00000574481.6 | NP_001898.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CTRL | ENST00000574481.6 | c.335G>A | p.Ser112Asn | missense_variant | 5/7 | 1 | NM_001907.3 | ENSP00000458537.2 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152174Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000183 AC: 46AN: 251164Hom.: 0 AF XY: 0.000184 AC XY: 25AN XY: 135758
GnomAD4 exome AF: 0.0000930 AC: 136AN: 1461796Hom.: 1 Cov.: 33 AF XY: 0.0000921 AC XY: 67AN XY: 727182
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152174Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74328
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2024 | The c.335G>A (p.S112N) alteration is located in exon 5 (coding exon 5) of the CTRL gene. This alteration results from a G to A substitution at nucleotide position 335, causing the serine (S) at amino acid position 112 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at